Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Bristol-Myers Squibb
Merck
Achillion
Bristol-Myers Squibb Earnings: Experts & Crowd Expect 10% EPS Growth
Yahoo/Benzinga
Mon, 04/27/15 - 09:23 pm
Bristol-Myers Squibb
earnings
Bristol-Myers says hepatitis C drug combination succeeds in study
Yahoo/Reuters
Sun, 04/26/15 - 09:18 am
Bristol-Myers Squibb
hepatitis C
daclatasvir
3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings
24/7 Wall St
Mon, 04/20/15 - 11:00 am
earnings
Eli Lilly
Bristol-Myers Squibb
AbbVie
Bristol-Myers: 2 immunotherapy drugs up survival over 1 in melanoma, but worsen side effects
Yahoo/AP
Mon, 04/20/15 - 10:34 am
Bristol-Myers Squibb
Yervoy
Opdivo
melanoma
With Bristol-Myers Trial Stopped Early, 'What's Next?'
Yahoo/Benzinga
Sat, 04/18/15 - 12:11 pm
Bristol-Myers Squibb
Opdivo
Bristol-Myers Zigs While Market Zags
WSJ Online
Sat, 04/18/15 - 12:03 pm
Bristol-Myers Squibb
It's A Big Weekend For Biotech
Yahoo/Benzinga
Sat, 04/18/15 - 11:55 am
biotech
Biogen
BIIB037
RG7800
PTC Therapeutics
Alnylam
CAR-T
Merck
Bristol-Myers Squibb
Novartis
Juno Therapeutics
Bellicum
Otsuka pulling out all the stops to deter copycats of blockbuster Abilify
BioPharma Dive
Fri, 04/17/15 - 10:36 am
Otsuka
Abilify
Bristol-Myers Squibb
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
Fri, 04/17/15 - 08:42 am
AbbVie
AstraZeneca
Biomarin
Bristol-Myers Squibb
Celgene
Gilead Sciences
GSK
Hospira
Jazz Pharmaceuticals
Merck
Seattle Genetics
Shire
Lilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America
Yahoo
Thu, 04/16/15 - 01:06 pm
Eli Lilly
Bristol-Myers Squibb
Erbitux
UniQure plans $100M follow-on offering in afterglow of big-ticket Bristol deal
Fierce Biotech
Wed, 04/8/15 - 12:08 pm
uniQure
Bristol-Myers Squibb
M&A
Pfizer, Eli Lilly Were The Original Medical Marijuana Sellers
Forbes
Wed, 04/8/15 - 12:03 pm
Medical Marijuana
Pfizer
Eli Lilly
Bristol-Myers Squibb
Bristol-Myers Squibb Completes Previously Announced Acquisition of Flexus Biosciences, Inc.
Yahoo
Wed, 04/8/15 - 11:00 am
Bristol-Myers Squibb
Flexus
M&A
10 Largest Companies by Market Cap in Pharmaceuticals
Motley Fool
Mon, 04/6/15 - 05:37 pm
JNJ
Novartis
Pfizer
Merck
Sanofi
GSK
Bristol-Myers Squibb
AbbVie
AstraZeneca
Eli Lilly
Bristol-Myers buys into Dutch gene therapy company uniQure
Yahoo/Reuters
Mon, 04/6/15 - 10:08 am
Bristol-Myers Squibb
uniQure
gene therapy
New cancer drugs "vastly overestimated", says contrarian analyst
Yahoo/Reuters
Tue, 03/31/15 - 12:46 pm
cancer
PD-1 inhibitors
PDL-1 inhibitors
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
Opdivo, Praluent and LCZ-696 top a launch crop poised for $27B in sales
Fierce Pharma Marketing
Wed, 03/25/15 - 03:13 pm
drug launches
Opdivo
Bristol-Myers Squibb
Praluent
Sanofi
Regeneron
LCZ696
Novartis
Bristol-Myers buys rights to Novo Nordisk immune system project
Yahoo/Reuters
Tue, 03/24/15 - 10:30 am
Novo Nordisk
Bristol-Myers Squibb
autoimmune disease
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »